2025年人工智慧（AI）病理品管全球市場報告

近年來，人工智慧（AI）病理品管市場發展迅速，預計從2024年的14.6億美元成長到2025年的17.8億美元，複合年成長率（CAGR）為21.6%。這段時期推動市場成長的主要因素包括癌症和慢性病盛行率的上升、對診斷準確性的需求不斷成長、熟練病理學家短缺、醫療保健支出增加以及個人化醫療的發展。

預計未來幾年，人工智慧（AI）病理品管市場將呈指數級成長，到2029年市場規模將達到38.4億美元，複合年成長率（CAGR）為21.2%。預測期內的成長主要受以下因素驅動：對自動化品質保證的需求不斷成長、對醫療保健AI新興企業的投資增加、雲端基礎病理解決方案的普及、精準醫療舉措的擴展以及對早期疾病檢測的日益重視。這段時期的關鍵趨勢包括：深度學習演算法的進步、品質控制自動化工具的創新、數位病理平台與人工智慧的融合、雲端基礎病理系統的開發以及多模態診斷分析的進步。

個人化醫療需求的不斷成長預計將推動人工智慧（AI）病理品管市場的擴張。個人化醫療是指根據個人的基因組成、生活方式和環境因素來制定個人化的治療和預防策略。個人化醫療的廣泛應用主要歸功於基因組學的進步，這使得基因突變的識別更加精準，並促進了標靶治療的開發。人工智慧驅動的病理品管透過提供準確一致的診斷資訊來增強個人化醫療，並有助於制定個人化的治療方案。自動化品質檢查可以最大限度地減少診斷錯誤，提高準確性和可靠性，並推動個人化醫療的發展。例如，美國非營利組織個人化醫療聯盟（PMC）報告稱，美國食品藥物管理局（FDA）在2023年核准了26種個人化新藥，較2022年的12種顯著增加。這種對個人化醫療日益成長的需求預計將推動人工智慧病理品管市場的發展。

人工智慧（AI）病理品管市場的關鍵參與者正致力於開發先進的解決方案，例如人工智慧驅動的技術，以提高診斷準確性、簡化檢查室工作流程並確保病理數據的可靠性。這些新一代人工智慧解決方案能夠執行複雜的任務，同時提高速度、準確性和效率。例如，總部位於美國的生物技術公司PathAI於2023年11月在其AISight數位病理平台上推出了Artifact Detect 1。該工具可自動偵測並量化全切片影像（WSI）中的偽影。透過自動篩檢切片中的品質問題，Artifact Detect可防止誤診和不必要的重複掃描，從而提高準確性、檢查室效率和整體吞吐量。它還能及時採取糾正措施，例如重新染色和重新掃描，從而改善數位化工作流程並節省病理學家和技術人員的資源。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球人工智慧（AI）病理品管：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 終端用戶產業分析
• 全球人工智慧（AI）病理品管市場：成長率分析
• 全球人工智慧（AI）病理品管市場表現：規模與成長，2019-2024年
• 全球人工智慧（AI）病理品管市場預測：規模與成長，2024-2029年，2034年
• 全球人工智慧（AI）病理品管：潛在市場規模（TAM）

第6章 市場細分

• 全球人工智慧（AI）病理品管市場：按組件、性能和預測分類，2019-2024年、2024-2029年、2034年
• 軟體
• 硬體
• 服務
• 全球人工智慧（AI）病理品管市場：按部署模式、性能和預測分類，2019-2024年、2024-2029年、2034年
• 本地部署
• 雲端基礎的
• 全球人工智慧（AI）病理品管市場：按應用、性能和預測分類，2019-2024年、2024-2029年、2034年
• 癌症診斷
• 感染疾病診斷
• 數位病理學
• 研究
• 其他用途
• 全球人工智慧（AI）病理品管市場按最終用戶、性能和預測分類，2019-2024年、2024-2029年、2034年
• 醫院
• 診斷實驗室
• 研究所
• 製藥和生物技術公司
• 其他最終用戶
• 全球人工智慧（AI）病理品管市場：按軟體、類型、性能和預測進行細分，2019-2024年、2024-2029年、2034年
• 影像分析軟體
• 診斷決策支援軟體
• 工作流程管理軟體
• 彙報和視覺化軟體
• 全球人工智慧（AI）病理品管市場：按硬體、類型、性能和預測進行細分，2019-2024年、2024-2029年、2034年
• 數位病理掃描儀
• 影像設備
• 伺服器和儲存系統
• 實驗室設備
• 全球人工智慧（AI）病理品管市場：按服務、類型、性能和預測進行細分，2019-2024年、2024-2029年、2034年
• 實施服務
• 培訓和支援服務
• 維護和升級服務
• 諮詢服務

第7章 區域和國家分析

• 全球人工智慧（AI）病理品管市場按地區、業績和預測分類，2019-2024年、2024-2029年、2034年
• 全球人工智慧（AI）病理品管市場：國家、績效與預測，2019-2024年、2024-2029年、2034年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

• 人工智慧（AI）病理品管市場：競爭格局
• 人工智慧（AI）病理品管市場：公司概況
  • Roche Diagnostics GmbH Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Philips Healthcare Overview, Products and Services, Strategy and Financial Analysis
  • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

• Clinisys Group Ltd.
• Sectra AB
• PathAI Inc.
• OptraSCAN Inc.
• Paige.AI Inc.
• Proscia Inc.
• Quibim SL
• 3DHISTECH Ltd.
• Visiopharm A/S
• Indica Labs Inc.
• Ibex Medical Analytics Ltd.
• Aiosyn BV
• DeepBio Inc.
• Nucleai Ltd.
• Gestalt Diagnostics LLC

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

• 2029年人工智慧（AI）病理品管市場：提供新機會的國家
• 2029年人工智慧（AI）病理品管市場：新興細分市場機會
• 2029年人工智慧（AI）病理品管市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第36章附錄

Artificial intelligence (AI) pathology quality control involves using AI algorithms and machine learning models to automatically evaluate and ensure the accuracy, consistency, and reliability of pathology data and slide interpretations. Its primary goal is to identify errors, standardize analyses, and enhance diagnostic precision in histopathology and cytopathology workflows, ultimately improving patient outcomes.

The main components of AI pathology quality control include software, hardware, and services. The software consists of AI-driven platforms and applications for automated analysis, quality assessment, and error detection in pathology workflows. These solutions can be deployed on-premises or via cloud-based systems. Applications include cancer diagnostics, infectious disease detection, digital pathology, research, and related areas, serving hospitals, diagnostic laboratories, research institutes, pharmaceutical and biotechnology companies, and other key end users.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The artificial intelligence (AI) pathology quality control market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI) pathology quality control market statistics, including the artificial intelligence (AI) pathology quality control industry global market size, regional shares, competitors with the artificial intelligence (AI) pathology quality control market share, detailed artificial intelligence (AI) pathology quality control market segments, market trends, and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) pathology quality control industry. This artificial intelligence (AI) pathology quality control market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The artificial intelligence (AI) pathology quality control market size has grown exponentially in recent years. It will grow from $1.46 billion in 2024 to $1.78 billion in 2025 at a compound annual growth rate (CAGR) of 21.6%. The growth during the historic period is driven by rising prevalence of cancer and chronic diseases, increasing demand for diagnostic accuracy, shortage of skilled pathologists, higher healthcare expenditure, and growth of personalized medicine.

The artificial intelligence (AI) pathology quality control market size is expected to see exponential growth in the next few years. It will grow to $3.84 billion in 2029 at a compound annual growth rate (CAGR) of 21.2%. The projected growth in the forecast period is supported by rising demand for automated quality assurance, increasing investment in healthcare AI startups, adoption of cloud-based pathology solutions, expansion of precision medicine initiatives, and greater focus on early disease detection. Key trends in this period include advancements in deep learning algorithms, innovations in QC automation tools, integration of AI with digital pathology platforms, development of cloud-based pathology systems, and progress in multimodal diagnostic analytics.

The growing demand for personalized medicine is expected to drive the expansion of the artificial intelligence (AI) pathology quality control market. Personalized medicine involves tailoring treatment and prevention strategies to an individual's genetic makeup, lifestyle, and environmental factors. The rise in personalized medicine adoption is largely attributed to advancements in genomics, which enable more precise identification of genetic variations and the development of targeted treatments. AI-powered pathology quality control enhances personalized medicine by offering accurate and consistent diagnostic insights, facilitating the creation of individualized treatment plans. It minimizes diagnostic errors by automating quality checks, improving accuracy and reliability, and advancing patient-specific care. For example, the Personalized Medicine Coalition (PMC), a US-based nonprofit, reported that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a significant increase from 12 in 2022. This growing demand for personalized medicine is expected to propel the AI pathology quality control market.

Key players in the artificial intelligence (AI) pathology quality control market are focusing on developing advanced solutions, such as AI-powered technologies, to enhance diagnostic precision, streamline laboratory workflows, and ensure the reliability of pathology data. These next-generation AI solutions perform complex tasks with improved speed, accuracy, and efficiency. For instance, in November 2023, PathAI, a US-based biotechnology company, introduced Artifact Detect 1 on its AISight digital pathology platform. This tool automates the detection and quantification of artifacts in whole slide images (WSI), which are non-relevant features that can reduce diagnostic accuracy. ArtifactDetect helps prevent misdiagnoses and unnecessary rescans by automatically screening slides for quality issues, boosting accuracy, laboratory efficiency, and overall throughput. It enables timely corrective actions, such as re-staining or re-scanning, improving digital workflows and conserving resources for pathologists and technicians.

In November 2024, Molbio Diagnostics Pvt. Ltd., an India-based molecular diagnostics company, acquired a majority stake in OptraSCAN Inc. through a $30 million investment. This acquisition enables Molbio to expand its presence in digital and AI-driven pathology, broaden its diagnostic portfolio beyond molecular testing, enhance its global market reach, and accelerate innovation in pathology quality control and precision diagnostics. OptraSCAN Inc., based in the US, provides AI solutions for pathology quality control as part of its digital pathology offerings.

Major players in the artificial intelligence (AI) pathology quality control market are Roche Diagnostics GmbH, Danaher Corporation, Philips Healthcare, Agilent Technologies Inc., Hologic Inc., Clinisys Group Ltd., Sectra AB, PathAI Inc., OptraSCAN Inc., Paige.AI Inc., Proscia Inc., Quibim S.L., 3DHISTECH Ltd., Visiopharm A/S, Indica Labs Inc., Ibex Medical Analytics Ltd., Aiosyn B.V., DeepBio Inc., Nucleai Ltd., and Gestalt Diagnostics LLC.

North America was the largest region in the artificial intelligence (AI) pathology quality control market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence (AI) pathology quality control report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the artificial intelligence (AI) pathology quality control market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI) pathology quality control market consists of revenues earned by entities by providing services such as automated slide review, error detection in pathology reports, consistency checks in histopathology and cytopathology analyses, digital image analysis, workflow optimization, and validation of diagnostic results using AI-powered tools. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) pathology quality control market also includes sales of artificial intelligence (AI)-powered pathology software, digital pathology platforms, image analysis tools, and quality assurance modules. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence (AI) Pathology Quality Control Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence (ai) pathology quality control market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence (ai) pathology quality control ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai) pathology quality control market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Component: Software; Hardware; Services
• 2) By Deployment Mode: On-Premises; Cloud-Based
• 3) By Application: Cancer Diagnostics; Infectious Disease Diagnostics; Digital Pathology; Research; Other Applications
• 4) By End-User: Hospitals; Diagnostic Laboratories; Research Institutes; Pharmaceutical And Biotechnology Companies; Other End Users
• Subsegments:
• 1) By Software: Image Analysis Software; Diagnostic Decision Support Software; Workflow Management Software; Reporting And Visualization Software
• 2) By Hardware: Digital Pathology Scanners; Imaging Devices; Servers And Storage Systems; Laboratory Equipment
• 3) By Services: Implementation Services; Training And Support Services; Maintenance And Upgrade Services; Consulting Services
• Companies Mentioned: Roche Diagnostics GmbH; Danaher Corporation; Philips Healthcare; Agilent Technologies Inc.; Hologic Inc.; Clinisys Group Ltd.; Sectra AB; PathAI Inc.; OptraSCAN Inc.; Paige.AI Inc.; Proscia Inc.; Quibim S.L.; 3DHISTECH Ltd.; Visiopharm A/S; Indica Labs Inc.; Ibex Medical Analytics Ltd.; Aiosyn B.V.; DeepBio Inc.; Nucleai Ltd.; Gestalt Diagnostics LLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Intelligence (AI) Pathology Quality Control Market Characteristics

3. Artificial Intelligence (AI) Pathology Quality Control Market Trends And Strategies

4. Artificial Intelligence (AI) Pathology Quality Control Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Intelligence (AI) Pathology Quality Control Growth Analysis And Strategic Analysis Framework

• 5.1. Global Artificial Intelligence (AI) Pathology Quality Control PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Artificial Intelligence (AI) Pathology Quality Control Market Growth Rate Analysis
• 5.4. Global Artificial Intelligence (AI) Pathology Quality Control Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Artificial Intelligence (AI) Pathology Quality Control Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Artificial Intelligence (AI) Pathology Quality Control Total Addressable Market (TAM)

6. Artificial Intelligence (AI) Pathology Quality Control Market Segmentation

• 6.1. Global Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Software
• Hardware
• Services
• 6.2. Global Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• On-Premises
• Cloud-Based
• 6.3. Global Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cancer Diagnostics
• Infectious Disease Diagnostics
• Digital Pathology
• Research
• Other Applications
• 6.4. Global Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostic Laboratories
• Research Institutes
• Pharmaceutical And Biotechnology Companies
• Other End Users
• 6.5. Global Artificial Intelligence (AI) Pathology Quality Control Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Image Analysis Software
• Diagnostic Decision Support Software
• Workflow Management Software
• Reporting And Visualization Software
• 6.6. Global Artificial Intelligence (AI) Pathology Quality Control Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Digital Pathology Scanners
• Imaging Devices
• Servers And Storage Systems
• Laboratory Equipment
• 6.7. Global Artificial Intelligence (AI) Pathology Quality Control Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Implementation Services
• Training And Support Services
• Maintenance And Upgrade Services
• Consulting Services

7. Artificial Intelligence (AI) Pathology Quality Control Market Regional And Country Analysis

• 7.1. Global Artificial Intelligence (AI) Pathology Quality Control Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Artificial Intelligence (AI) Pathology Quality Control Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence (AI) Pathology Quality Control Market

• 8.1. Asia-Pacific Artificial Intelligence (AI) Pathology Quality Control Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence (AI) Pathology Quality Control Market

• 9.1. China Artificial Intelligence (AI) Pathology Quality Control Market Overview
• 9.2. China Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence (AI) Pathology Quality Control Market

• 10.1. India Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence (AI) Pathology Quality Control Market

• 11.1. Japan Artificial Intelligence (AI) Pathology Quality Control Market Overview
• 11.2. Japan Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence (AI) Pathology Quality Control Market

• 12.1. Australia Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence (AI) Pathology Quality Control Market

• 13.1. Indonesia Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence (AI) Pathology Quality Control Market

• 14.1. South Korea Artificial Intelligence (AI) Pathology Quality Control Market Overview
• 14.2. South Korea Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence (AI) Pathology Quality Control Market

• 15.1. Western Europe Artificial Intelligence (AI) Pathology Quality Control Market Overview
• 15.2. Western Europe Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence (AI) Pathology Quality Control Market

• 16.1. UK Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence (AI) Pathology Quality Control Market

• 17.1. Germany Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence (AI) Pathology Quality Control Market

• 18.1. France Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence (AI) Pathology Quality Control Market

• 19.1. Italy Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence (AI) Pathology Quality Control Market

• 20.1. Spain Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence (AI) Pathology Quality Control Market

• 21.1. Eastern Europe Artificial Intelligence (AI) Pathology Quality Control Market Overview
• 21.2. Eastern Europe Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence (AI) Pathology Quality Control Market

• 22.1. Russia Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence (AI) Pathology Quality Control Market

• 23.1. North America Artificial Intelligence (AI) Pathology Quality Control Market Overview
• 23.2. North America Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence (AI) Pathology Quality Control Market

• 24.1. USA Artificial Intelligence (AI) Pathology Quality Control Market Overview
• 24.2. USA Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence (AI) Pathology Quality Control Market

• 25.1. Canada Artificial Intelligence (AI) Pathology Quality Control Market Overview
• 25.2. Canada Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence (AI) Pathology Quality Control Market

• 26.1. South America Artificial Intelligence (AI) Pathology Quality Control Market Overview
• 26.2. South America Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence (AI) Pathology Quality Control Market

• 27.1. Brazil Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence (AI) Pathology Quality Control Market

• 28.1. Middle East Artificial Intelligence (AI) Pathology Quality Control Market Overview
• 28.2. Middle East Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence (AI) Pathology Quality Control Market

• 29.1. Africa Artificial Intelligence (AI) Pathology Quality Control Market Overview
• 29.2. Africa Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Artificial Intelligence (AI) Pathology Quality Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence (AI) Pathology Quality Control Market Competitive Landscape And Company Profiles

• 30.1. Artificial Intelligence (AI) Pathology Quality Control Market Competitive Landscape
• 30.2. Artificial Intelligence (AI) Pathology Quality Control Market Company Profiles
  • 30.2.1. Roche Diagnostics GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Philips Healthcare Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence (AI) Pathology Quality Control Market Other Major And Innovative Companies

• 31.1. Clinisys Group Ltd.
• 31.2. Sectra AB
• 31.3. PathAI Inc.
• 31.4. OptraSCAN Inc.
• 31.5. Paige.AI Inc.
• 31.6. Proscia Inc.
• 31.7. Quibim S.L.
• 31.8. 3DHISTECH Ltd.
• 31.9. Visiopharm A/S
• 31.10. Indica Labs Inc.
• 31.11. Ibex Medical Analytics Ltd.
• 31.12. Aiosyn B.V.
• 31.13. DeepBio Inc.
• 31.14. Nucleai Ltd.
• 31.15. Gestalt Diagnostics LLC

32. Global Artificial Intelligence (AI) Pathology Quality Control Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence (AI) Pathology Quality Control Market

34. Recent Developments In The Artificial Intelligence (AI) Pathology Quality Control Market

35. Artificial Intelligence (AI) Pathology Quality Control Market High Potential Countries, Segments and Strategies

• 35.1 Artificial Intelligence (AI) Pathology Quality Control Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Artificial Intelligence (AI) Pathology Quality Control Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Artificial Intelligence (AI) Pathology Quality Control Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer